Transaction · 0001106578-26-000133

ROTHBLATT MARTINE A

ROTHBLATT MARTINE A, CHAIR, CEO, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 825.000000 shares for an estimated $422359.16. Reported holdings after the transaction were 332798.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR, CEO
UTHRUNITED THERAPEUTICS Corp
Filing timeSep 02
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$492.02
Pre-filing
1mo ago +5.2%1w ago +5.3%1d ago +3.7%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001106578-26-000133
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 02, 2026, 08:34 PM · 1d delay
Shares
825 sh
$51.1k per share
Estimated value
-$42.2M
Computed from shares × price
Holdings after
332k sh
Indirect · by Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Repeat Seller 10b5-1 Detected
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairperson & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will c…

  2. F10

    Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  3. F11

    Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

  4. F12

    Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

  5. F2

    Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  6. F3

    This transaction was executed in multiple trades at prices ranging from $510.43 to $511.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F4

    This transaction was executed in multiple trades at prices ranging from $511.58 to $512.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  8. F5

    This transaction was executed in multiple trades at prices ranging from $512.59 to $513.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  9. F6

    This transaction was executed in multiple trades at prices ranging from $513.59 to $514.585. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  10. F7

    This transaction was executed in multiple trades at prices ranging from $514.59 to $515.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  11. F8

    This transaction was executed in multiple trades at prices ranging from $515.59 to $516.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  12. F9

    Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

Original filing · 0001106578-26-000133
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR